LT2231189T - Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui - Google Patents

Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui

Info

Publication number
LT2231189T
LT2231189T LTEP08861526.5T LT08861526T LT2231189T LT 2231189 T LT2231189 T LT 2231189T LT 08861526 T LT08861526 T LT 08861526T LT 2231189 T LT2231189 T LT 2231189T
Authority
LT
Lithuania
Prior art keywords
administration
delivery system
drug delivery
water soluble
active substances
Prior art date
Application number
LTEP08861526.5T
Other languages
English (en)
Inventor
Julian Aleksov
Igor Lokot
Original Assignee
Ardenia Investments Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40795732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2231189(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardenia Investments Ltd. filed Critical Ardenia Investments Ltd.
Publication of LT2231189T publication Critical patent/LT2231189T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEP08861526.5T 2007-12-19 2008-12-18 Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui LT2231189T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/SE2007/001127 WO2009078754A1 (en) 2007-12-19 2007-12-19 Drug delivery system for administration of poorly water soluble pharmaceutically active substances
PCT/SE2008/051515 WO2009078802A1 (en) 2007-12-19 2008-12-18 Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Publications (1)

Publication Number Publication Date
LT2231189T true LT2231189T (lt) 2017-12-27

Family

ID=40795732

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP08861526.5T LT2231189T (lt) 2007-12-19 2008-12-18 Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui
LTPA2019508C LTPA2019508I1 (lt) 2007-12-19 2019-04-25 Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTPA2019508C LTPA2019508I1 (lt) 2007-12-19 2019-04-25 Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui

Country Status (27)

Country Link
US (4) US8999382B2 (lt)
EP (1) EP2231189B1 (lt)
JP (1) JP5466172B2 (lt)
KR (1) KR101572703B1 (lt)
CN (1) CN101951956B (lt)
AU (1) AU2008339099B2 (lt)
BR (1) BRPI0821740B1 (lt)
CA (1) CA2709266C (lt)
CY (2) CY1119805T1 (lt)
DK (1) DK2231189T3 (lt)
EA (1) EA015247B1 (lt)
ES (1) ES2650242T3 (lt)
FR (1) FR19C1030I1 (lt)
HR (1) HRP20171796T1 (lt)
HU (1) HUE034684T2 (lt)
LT (2) LT2231189T (lt)
LU (1) LUC00117I2 (lt)
MX (1) MX2010006914A (lt)
MY (2) MY157186A (lt)
NL (1) NL300987I9 (lt)
NO (2) NO2231189T3 (lt)
NZ (1) NZ586859A (lt)
PL (1) PL2231189T3 (lt)
PT (1) PT2231189T (lt)
SI (1) SI2231189T1 (lt)
WO (2) WO2009078754A1 (lt)
ZA (1) ZA201004685B (lt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078754A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2009078756A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
EP2421561A2 (en) * 2009-04-21 2012-02-29 Selecta Biosciences, Inc. Immunonanotherapeutics providing a th1-biased response
EP2575773A4 (en) 2010-05-26 2014-06-25 Selecta Biosciences Inc SYNTHETIC NANOTRÄGERKOMBINATIONSIMPFSTOFFE
EA201390660A1 (ru) 2010-11-05 2013-11-29 Селекта Байосайенсиз, Инк. Модифицированные никотиновые соединения и связанные способы
CN103908432B (zh) * 2013-01-02 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种伊沙匹隆白蛋白的冻干组合物及其制备方法
CN112321465B (zh) * 2019-07-18 2023-06-06 上海现代药物制剂工程研究中心有限公司 一种含苯基化合物、其中间体、制备方法及应用
CN112239418B (zh) * 2019-07-18 2023-07-07 上海现代药物制剂工程研究中心有限公司 视黄醇类化合物及其钠盐的制备方法
WO2021259472A1 (en) * 2020-06-24 2021-12-30 Oasmia Pharmaceutical Ab Micellar docetaxel for use in the treatment of cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
DE19839566C2 (de) * 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
US6197809B1 (en) * 1998-12-23 2001-03-06 Ardenia Investments Ltd. Compounds for the treatment of cancer
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
SE0101702D0 (sv) * 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
US20050191359A1 (en) * 2001-09-28 2005-09-01 Solubest Ltd. Water soluble nanoparticles and method for their production
US20050249786A1 (en) * 2001-09-28 2005-11-10 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
SE0202311D0 (sv) * 2002-07-23 2002-07-23 Ardenia Investments Ltd Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
CN100360502C (zh) * 2002-07-23 2008-01-09 阿登尼亚投资有限公司 视黄醇衍生物、它们在治疗癌症和增强其它细胞毒性剂功效中的应用
US7259984B2 (en) * 2002-11-26 2007-08-21 Cornell Research Foundation, Inc. Multibit metal nanocrystal memories and fabrication
JP2006199590A (ja) 2003-09-04 2006-08-03 Nano Career Kk 水溶性の塩基性薬物内包ナノ粒子含有組成物
US20050196343A1 (en) 2004-02-27 2005-09-08 Molecular Therapeutics, Inc. Degradable nanoparticles
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
WO2007001356A2 (en) * 2004-09-10 2007-01-04 University Of Wyoming Nanoparticles for cytoplasmic drug delivery to cancer cells
KR101643416B1 (ko) * 2005-08-31 2016-07-27 아브락시스 바이오사이언스, 엘엘씨 증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조방법
WO2009078756A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2009078755A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance

Also Published As

Publication number Publication date
PL2231189T3 (pl) 2018-03-30
WO2009078802A1 (en) 2009-06-25
DK2231189T3 (en) 2017-12-11
BRPI0821740A2 (pt) 2020-02-27
HRP20171796T1 (hr) 2018-01-26
MX2010006914A (es) 2010-11-10
EA015247B1 (ru) 2011-06-30
CA2709266A1 (en) 2009-06-25
NO2231189T3 (lt) 2018-02-03
SI2231189T1 (en) 2018-03-30
MY157186A (en) 2016-05-13
US8999382B2 (en) 2015-04-07
JP5466172B2 (ja) 2014-04-09
CN101951956B (zh) 2012-10-17
ZA201004685B (en) 2011-03-30
AU2008339099B2 (en) 2015-08-13
US9993438B2 (en) 2018-06-12
EP2231189B1 (en) 2017-09-06
BRPI0821740B1 (pt) 2021-05-18
NL300987I9 (nl) 2019-05-16
KR20100094575A (ko) 2010-08-26
US20150164819A1 (en) 2015-06-18
MY157187A (en) 2016-05-13
FR19C1030I1 (fr) 2019-06-21
LTPA2019508I1 (lt) 2019-05-10
CY1119805T1 (el) 2018-06-27
CY2019021I2 (el) 2019-11-27
NO2019023I1 (no) 2019-05-08
EP2231189A1 (en) 2010-09-29
CA2709266C (en) 2017-09-26
CY2019021I1 (el) 2019-11-27
WO2009078754A1 (en) 2009-06-25
ES2650242T3 (es) 2018-01-17
NZ586859A (en) 2012-06-29
PT2231189T (pt) 2017-12-12
LUC00117I2 (lt) 2024-05-22
EA200802350A3 (ru) 2009-10-30
KR101572703B1 (ko) 2015-11-27
AU2008339099A1 (en) 2009-06-25
CN101951956A (zh) 2011-01-19
USRE49742E1 (en) 2023-12-05
NL300987I2 (lt) 2019-05-09
HUE034684T2 (en) 2018-02-28
EA200802350A2 (ru) 2009-06-30
JP2011507838A (ja) 2011-03-10
USRE49741E1 (en) 2023-12-05
US20110014281A1 (en) 2011-01-20
EP2231189A4 (en) 2013-10-09

Similar Documents

Publication Publication Date Title
ZA201004685B (en) Drug delivery system for administration of poorly water soluble pharmaceutically active substances
IL202614A0 (en) Intravaginal drug delivery devices for the delivery of macromolecules and water soluble drugs
WO2009088414A3 (en) Oral pharmaceutical dosage forms
IL218165A (en) Stable Pharmaceutical Formulations Highly Concentrated to Provide Subcutaneous Active Pharmaceutical Antibody against CD20
IL227898A (en) A drug delivery system with a small amount of drug component
EP2056792A4 (en) DRUG DELIVERY SYSTEMS WITH SOLID SOLUTIONS FROM LIGHT BASIC ACTIVE SUBSTANCES
EP2213318A4 (en) DRUG SOLUTION DELIVERY SYSTEM AND DRUG SOLUTION ADMINISTRATION CANNULA
EP1993518A4 (en) DOSAGE FORMS FOR THE ADMINISTRATION OF MEDICINAL COMBINATIONS
EP1983930A4 (en) DELIVERY SYSTEM FOR DELAYED RELEASE MEDICATION OF WATER-SOLUBLE SUBSTANCES
EP2023900A4 (en) DRUG DELIVERY SYSTEM WITH CONTROLLED DOSES
IL196394A0 (en) Implantable sustained drug delivery device for releasing active agents to the osteomeatal complex
HRP20181517T1 (hr) Sustav dostave lijeka za administraciju u vodi topljive, kationske i amfifilne farmaceutski aktivne tvari
EP2150235A4 (en) Capsule formulation coated with nanoparticles for the purpose of dermal drug administration
EP2231192A4 (en) DRUG DISPENSING SYSTEM FOR THE ADMINISTRATION OF A WATER-SOLUBLE, CATIONIC AND AMPHIPHILIC PHARMACEUTICAL ACTIVE SUBSTANCE
EP2012705A4 (en) PHARMACEUTICAL FORMULATIONS FOR IONTOPHORETIC ACTIVE INJECTION
ZA201400938B (en) Dissolution enhanced controlled drug delivery system for poorly water soluble drugs
ZA200807348B (en) Dosage aerosols for the administration of pharmaceutical preparations
ZA201006517B (en) Estradiol-containing drug delivery system
ZA200802187B (en) Drug delivery system for topical administration
ZA200901366B (en) Drug delivery systems comprising solid solutions of weakly basic drugs
PL2338473T3 (pl) Postacie farmaceutycznej dawki tizanidyny i drogi jej podawania
EP2068847A4 (en) PREPARATION AND COMPOSITION OF A TRANSDERMAL DRUG DISPENSING SYSTEM WITH MELOXICAM
ZA200904563B (en) Transdermal Therapeutic system for administering water-soluble active ingredients
IL217067A (en) A drug release system for the delivery of pharmaceutical preparations to perforations in the body
AU2007902112A0 (en) Nanoparticle-coated capsule formulation for dermal drug delivery